LIVINGSTON. P. G., KURANE, I., DAI, L. C., OKAMOTO, Y., LAI, C. J., MEN,
R., KARAKI, S., TAKIGUCHI, M., ENNIS, F. A. Dengue virus-specific, HLA-
B35-restricted, human CD8
+
cytotoxic T lymphocyte (CTL) clones. Recognition
of NS3 amino acids 500 to 508 by CTL clones of two different serotype
specificities. The Journal of Immunology. v. 154, n. 3, p. 1287-1295, 1995.
MALASIT, P. Complement and dengue haemorrhagic fever/shock syndrome.
SE Asian J. Trop. Med. Public Health. v. 18, n.3, p.316-320, 1987.
MARKOFF, L., PANG, X., HOUNG, H. S., FALGOUT, B., OLSEN, R., JONES,
E., POLO, S. Derivation and characterization of a dengue type 1 host range-
restricted mutant virus that is attenuated and highly immunogenic in monkeys.
Journal of Virology. v. 76, p. 3318-3328, 2002.
MATHEW, A., KURANE, I., GREEN, S., VAUGHN, D. W., KALAYANAROOJ,
S., SUNTAYAKORN, S., ENNIS, F. A., ROTHMAN, A. L. Impaired T cell
Proliferation in Acute Dengue Infection. The Journal of Immunology. v. 162, p.
5609-5615, 1999.
MONATH, T. P. Dengue: The risk to developed and developing countries.
Proceeding National Academy of Sciences, v.91, p. 2395-2400, 1994.
MURATA, K., LECHMANN, M., QIAO, M., GUNJI, T., ALTER, H.J., LIANG, T.
J. Immunization with hepatitis C virus-like particles protects mice from
recombinant hepatitis C virus-vaccinia infection. Proceeding National
Academy of Sciences. v. 100, n. 11, p. 6753-6758, 2003.
NEDWIN, G. E., SVEDERSKY, L. P., BRINGMAN, T. S., PALLADINO, M. A.,
GOEDDEL, D. V. Effect of interleukin 2, interferon-, and mitogens on the
production of tumor necrosis factors and . The Journal of Immunology. v.
135, n. 4, p. 2492-2497, 1985.